Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.
2.

[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].

Prygiel M, Janaszek-Seydlitz W, Bucholc B.

Przegl Epidemiol. 2011;65(4):621-8. Review. Polish.

PMID:
22390050
3.

Genomics of Mycobacterium bovis.

Gordon SV, Eiglmeier K, Garnier T, Brosch R, Parkhill J, Barrell B, Cole ST, Hewinson RG.

Tuberculosis (Edinb). 2001;81(1-2):157-63. Review.

PMID:
11463237
4.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Epub 2009 Feb 20. Review.

PMID:
19164935
5.

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.

Ganguly N, Siddiqui I, Sharma P.

Tuberculosis (Edinb). 2008 Nov;88(6):510-7. doi: 10.1016/j.tube.2008.05.002. Epub 2008 Jul 21. Review.

PMID:
18640874
6.

MPB70 and MPB83--major antigens of Mycobacterium bovis.

Wiker HG.

Scand J Immunol. 2009 Jun;69(6):492-9. doi: 10.1111/j.1365-3083.2009.02256.x. Review.

7.

Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP.

Green J, Scott C, Guest JR.

Adv Microb Physiol. 2001;44:1-34. Review.

PMID:
11407111
8.

Mycobacterial genome structure.

Philipp WJ, Schwartz DC, Telenti A, Cole ST.

Electrophoresis. 1998 Apr;19(4):573-6. Review.

PMID:
9588804
9.

DNA metabolism in mycobacterium tuberculosis: implications for drug resistance and strain variability.

Boshoff HI, Durbach SI, Mizrahi V.

Scand J Infect Dis. 2001;33(2):101-5. Review.

PMID:
11233842
10.

[Microbiological and immunological studies on mycobacteria, especially on the biologic activities of BCG.DNA].

Tokunaga T.

Nihon Saikingaku Zasshi. 1993 Nov;48(6):721-8. Review. Japanese. No abstract available.

PMID:
8309076
11.

Cyclic-AMP and bacterial cyclic-AMP receptor proteins revisited: adaptation for different ecological niches.

Green J, Stapleton MR, Smith LJ, Artymiuk PJ, Kahramanoglou C, Hunt DM, Buxton RS.

Curr Opin Microbiol. 2014 Apr;18:1-7. doi: 10.1016/j.mib.2014.01.003. Epub 2014 Feb 7. Review.

12.

Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?

Singh S, Kumar M, Singh P.

Tuberc Res Treat. 2015;2015:957519. doi: 10.1155/2015/957519. Epub 2015 Jan 28. Review.

Supplemental Content

Support Center